Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - George Vasmatzis, Ph.D.

Back to Research Profile

  1. Shin S, Kim TD, Jin F, van Deursen JM, Dehm SM, Tindall DJ, Grande JP, Munz JM, Vasmatzis G, Janknecht R. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Cancer Res 2009 Oct 15; 69(20):8102-10. Epub 2009 Sep 29.
    View PubMed
  2. Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Hum Pathol 2009 Aug; 40(8):1152-8. Epub 2009 Apr 22.
    View PubMed
  3. Savci-Heijink CD, Kosari F, Aubry MC, Caron BL, Sun Z, Yang P, Vasmatzis G. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol 2009 May; 174(5):1629-37. Epub 2009 Mar 26.
    View PubMed
  4. Klee EW, Erdogan S, Tillmans L, Kosari F, Sun Z, Wigle DA, Yang P, Aubry MC, Vasmatzis G. Impact of sample acquisition and linear amplification on gene expression profiling of lung adenocarcinoma: laser capture micro-dissection cell-sampling versus bulk tissue-sampling. BMC Med Genomics 2009; 2:13. Epub 2009 Mar 09.
    View PubMed
  5. Cheville JC, Karnes RJ, Therneau TM, Kosari F, Munz JM, Tillmans L, Basal E, Rangel LJ, Bergstralh E, Kovtun IV, Savci-Heijink CD, Klee EW, Vasmatzis G. Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol 2008 Aug 20; 26(24):3930-6.
    View PubMed
  6. Kosari F, Munz JM, Savci-Heijink CD, Spiro C, Klee EW, Kube DM, Tillmans L, Slezak J, Karnes RJ, Cheville JC, Vasmatzis G. Identification of prognostic biomarkers for prostate cancer. Clin Cancer Res 2008 Mar 15; 14(6):1734-43.
    View PubMed
  7. Vasmatzis G, Klee EW, Kube DM, Therneau TM, Kosari F. Quantitating tissue specificity of human genes to facilitate biomarker discovery. Bioinformatics 2007 Jun 1; 23(11):1348-55. Epub 2007 Mar 23.
    View PubMed
  8. Vasmatzis G, Klee EW, Kube DM, Therneau TM, Kosari F. Quantitating tissue specificity of human genes to facilitate biomarker discovery Bioinformatics.[Epub ahead of print] 2007 Mar 26.
    View PubMed
  9. Kube DM, Savci-Heijink DC, Lamblin AF, Vasmatzis G, Cheville JC, Connelly DP, Klee GG, Kosari F. Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer. BMC Molecular Biology 2007; 8(25).
  10. Kube DM, Savci-Heijink CD, Lamblin AF, Kosari F, Vasmatzis G, Cheville JC, Connelly DP, Klee GG. Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer. BMC Mol Biol 2007; 8:25.
    View PubMed
  11. Klee EW, Finlay JA, McDonald C, Attewell JR, Hebrink D, Dyer R, Love B, Vasmatzis G, Li TM, Beechem JM, Klee GG. Bioinformatics methods for prioritizing serum biomarker candidates. Clin Chem 2006 Nov; 52(11):2162-4.
    View PubMed
  12. Chang H, Venkatesan BM, Iqbal SM, Andreadakis G, Kosari F, Vasmatzis G, Peroulis D, Bashir R. DNA counterion current and saturation examined by a MEMS-based solid state nanopore sensor. Biomed Microdevices 2006 Sep; 8(3):263-9.
    View PubMed
  13. Wang X, Zheng L, Zeng Z, Zhou G, Chien J, Qian C, Vasmatzis G, Shridhar V, Chen L, Liu W. DIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding protein. Biochem Biophys Res Commun 2006 Aug 18; 347(1):22-30. Epub 2006 Jun 19.
    View PubMed
  14. Parker AS, Kosari F, Lohse CM, Thompson RH, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 2006 Jul 1; 107(1):37-45.
    View PubMed
  15. Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 2006 Jul 1; 107(1):37-45.
    View PubMed
  16. Murillo H, Schmidt LJ, Karter M, Hafner KA, Kondo Y, Ballman KV, Vasmatzis G, Jenkins RB, Tindall DJ. Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence. Genes Chromosomes Cancer 2006 Jul; 45(7):702-16.
    View PubMed
  17. Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Clear cell renal cell carcinoma: Gene expression analyses identify a potential signature for tumor aggressiveness. Clin Cancer Res 2005 Jul 15; 11(14):5128-39.
    View PubMed
  18. Sun Z, Yang P, Aubry MC, Kosari F, Endo C, Molina J, Vasmatzis G. Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung? Mol Cancer 2004 Dec 3; 3(1):35.
    View PubMed
  19. Yang P, Sun Z, Aubry MC, Kosari F, Bamlet W, Endo C, Molina JR, Vasmatzis G. Study design considerations in clinical outcome research of lung cancer using microarray analysis. Lung Cancer 2004 Nov; 46(2):215-26.
    View PubMed
  20. Chang H, Kosari F, Andreadakis G, Alam MA, Vasmatzis G, Bashir R. DNA-mediated fluctuations in ionic current through silicon oxide nanopore channels. Nano Letters 2004 Aug; 4(8):1551-6.
  21. Bergen HR III, Vasmatzis G, Cliby WA, Johnson KL, Oberg AL, Muddiman DC. Discovery of ovarian cancer biomarkers in serum using NanoLC electrospray ionization TOF and FT-ICR mass spectrometry. Dis Markers 2003/2004; 19(4-5):239-49.
  22. Kosari F, Asmann YW, Cheville JC, Vasmatzis G. Cysteine-rich secretory protein-3: A potential biomarker for prostate cancer. Cancer Epidemiol Biomarkers Prev 2002 Nov; 11(11):1419-26.
    View PubMed
  23. Chang H, Ikram A, Kosari F, Vasmatzis G, Bhunia A, Bashir R. Electrical characterization of micro-organisms using microfabricated devices. Journal of Vacuum Science & Technology B 2002 Sep-Oct; 20(5):2058-64.
  24. Chang H, Ikram A, Geng T, Kosari F, Vasmatzis G, Bhunia A, Bashir R. Electrical characterization of microorganisms using microfabricated devices. J VAC SCI TECHNOL B 2002 SEP-OCT; 20(5):2058-64.
  25. Asmann YW, Kosari F, Wang K, Cheville JC, Vasmatzis G. Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags. Cancer Res 2002 Jun 1; 62(11):3308-14.
    View PubMed
  26. Kosari F, Asmann YW, Cheville JC, Vasmatzis G. Identification of differentially expressed genes in prostate cancer by electronic profiling of Expressed Sequence Tags. Biophys J 2002 Jan; 82(1 Part 2):167a.
  27. Geanacopoulos M, Vasmatzis G, Zhurkin VB, Adhya S. Gal repressosome contains an antiparallel DNA loop. Nat Struct Biol 2001 May; 8(5):432-6.
    View PubMed
  28. Yerushalmi N, Keppler-Hafkemeyer A, Vasmatzis G, Liu XF, Olsson P, Bera TK, Duray P, Lee B, Pastan I. ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues. Gene 2001 Mar; 265(1-2):55-60.
  29. Geanacopoulos M, Vasmatzis G, Zhurkin V, Adhya S. Structure-based genetic analysis of Gal repressosome: GalR tetramer and the DNA loop it forms. Nat Struct Biol May 2001; 8(5):432-6.
  30. Liu XF, Essand M, Vasmatzis G, Lee B, Pastan I. Identification of three new alternate human kallikrein 2 transcripts: Evidence of long transcript and alternative splicing. Biochem Biophys Res Commun 1999; 264(3):833-9.
    View PubMed
  31. Essand M, Vasmatzis G, Brinkmann U, Lee B, Pastan I. High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate. Proc Natl Acad Sci USA 1999; 96(16):9287-92.
    View PubMed
  32. Vasmatzis G, Brinkmann U, Lee B, Pastan I. Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the EST database. Cancer Res 1999; 59(7):1445-8.
    View PubMed
  33. Onda M, Kreitman RJ, Vasmatzis G, Lee B, Pastan I. Reduction of the nonspecific toxicity of immunotoxin anti-Tac(Fv)-PE38 (LMB-2) by mutations in the Fv which lower the isoelectric point. Blood (Pt I Suppl 1), 1999; 94(10):1246.
  34. Geanacopoulos M, Vasmatzis G, Lewis DEA, Roy S, Lee B, Adhya S. GalR mutants diffective in repressosome formation. Genes & Development 1999; 13:1251-62.
    View PubMed
  35. Pastan L, Vasmatzis G, Essand M, Olsson P, Liu XF, Iavarone C, Ailey B, Duray P, Bera T, Lee B. Discovery of new targets for prostate cancer immunotherapy by EST database analysis. Clin Cancer Res Suppl S Nov 1999; 5:3869S-3869.
  36. Nambiar MP, Vasmatzis G, Lee BK, FitzGerald DJ, Pastan IH. Production of stable scFv by mutation of the unusual amino acids at the framework region. FASEB J 1998 Apr 24; 12(8 Suppl S):683.
    View PubMed
  37. Vasmatzis G, Essand M, Brinkmann U, Lee B, Pastan I. Discovery of three new genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc Natl Acad Sci USA 1998; 95(1):300-4.
    View PubMed
  38. Almog O, Benhar I, Vasmatzis G, Tordova M, Lee B, Pastan I, Gilliland G. The crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: Conformational influence of engineered disulfide bond. Proteins 1998; 31(2):128-38.
  39. Brinkmann U, Vasmatzis G, Lee B, Yerushalmi N, Essand M, Pastan I. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proc Natl Acad Sci USA 1998; 95(18):10757-62.
    View PubMed
  40. Chowdhury PS, Vasmatzis G, Beers R, Lee B, Pastan I. Improvement of the stability and yield of scFv immunotoxins by molecular modeling and protein engineering. FASEB J 1998; 12(8):681 Suppl S.
  41. Chowdhury PS, Vasmatzis G, Beers R, Lee B, Pastan I. Improvement of the stability and yield of K1 scFv immunotoxin by computer design and protein engineering. J Mol Biol 1998; 281(5):917-28.
    View PubMed
  42. Lee B, Vasmatzis G. Stabilization of protein structure. Curr Opin Biotechnol 1997; 8(4):423-8.
    View PubMed
  43. Brinkmann U, Carlo AD, Vasmatzis G, Kurochkina N, Beers R, Lee B, Pastan I. Stabilization of a recombinant Fv fragment by base-loop interconnection and v(h)-v(l) permutation. J Mol Biol 1997; 268(1):107-17.
    View PubMed
  44. Zhang C, Vasmatzis G, Cornette J, DeLisi C. Determination of atomic desolvation energies from the structures of crystallized proteins. J Mol Biol 1997; 267(3):707-26.
    View PubMed
  45. Vasmatzis G, Zhang C, Cornette J, DeLisi C. Computational of side chain specificity for pockets in class I MHC molecules. Mol Immunol 1996; 33(16):1231-9.
    View PubMed
  46. Vasmatzis G, Cornette J, Sezerman U, DeLisi C. TcR recognition of the MHC-peptide dimer: Structural properties of a ternary complex. J Mol Biol 1996; 261(1):72-89.
    View PubMed
  47. Vasmatzis G, Brower RC, DeLisi C. Predicting immunoglobulin-like hypervariable loops. Biopolymers 1994; 34:1669-80.
    View PubMed
  48. Brower RC, Vasmatzis G, Siverman M, DeLisi C. Peptide conformations on a lattice by exhaustive search and simulated annealing. Biopolymers 1993; 33:329-34.
    View PubMed


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.